KAYCE STREET: Open Payments
NPI 1407501935 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 33 payments from 14 companies in 2025. Trend: 2023 $389 · 2024 $570 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 8 | $182 |
| SHIELD THERAPEUTICS INC | 2 | $90 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $81 |
| Exeltis, USA Inc. | 3 | $53 |
| MILLICENT US INC | 2 | $45 |
| Astellas Pharma US Inc | 2 | $39 |
| Baxter Healthcare | 1 | $39 |
| PFIZER INC. | 2 | $37 |
| Evofem Biosciences, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
Products named: ZURZUVAE, ACCRUFER, SLYND, FEMLYV, Veozah, PERCLOT, ABRYSVO, Phexxi.
Industry payments across TX — which companies pay providers there.
